Guo Junming, Xiao Bingxiu, Zhang Xinjun, Jin Zhijin, Chen Jian, Qin Lijun, Mao Xiongying, Shen Guangyu, Chen Hui, Liu Zhong
School of Medicine, Ningbo University, 315211, Ningbo, China.
J Mol Med (Berl). 2004 Nov;82(11):768-74. doi: 10.1007/s00109-004-0590-8. Epub 2004 Oct 13.
To establish a novel molecular diagnostic method of detecting circulating tumor cells (CTCs) LS174T colon cancer cells were serially diluted with normal blood. Additional peripheral blood samples were collected from 25 patients with colorectal carcinoma. Mononuclear cells (MNCs) were collected, equally divided into four parts, and then cancer cells were enriched by four methods: method A, nonimmunobead method; method B, negative immunobead method: CD45 immunomagnetic beads were used to deplete the leukocytes; method C, positive immunobead method: Ber-EP4 immunomagnetic beads were used to enrich cancer cells; method D, negative-and-positive immunobead method: CD45 immunomagnetic beads were first used to deplete the leukocytes from MNC and then Ber-EP4 immunomagnetic beads were used to enrich cancer cells. Finally, real-time quantitative RT-PCR was used to monitor mRNA expression of beta2-mircoglobulin (beta2M) and carcinoembryonic antigen (CEA). The relative CEA mRNA values were corrected with reference to beta2M mRNA, to CEA mRNA/beta2M mRNA ratios according to a CEA mRNA external standards prepared with tenfold serial dilutions (1-10(4) IS174T cells) of cDNA and beta2M mRNA external standards prepared with tenfold serial dilutions (10(2)-10(7) leukocytes) of cDNA. In recovery experiments a significant correlation between the number of cancer cells and CEA mRNA expression was found when CD45 or Ber-EP4 immunomagnetic beads were used alone. A highly significant correlation was found when CD45 and Ber-EP4 immunomagnetic beads were used successively. The sensitivity of method D was one cancer cell per milliliter of blood. Circulating cancer cells were detected in 19 of 25 patients with colorectal cancers. The relative CEA mRNA value obtained by method D was the smallest. The positive detection rate of circulating cancer cells in patients at Dukes' B, C, and D stages were 25.0% (1/4), 83.3% (10/12), and 88.9% (8/9). Combinative use of immunomagnetic isolation followed by real-time RT-PCR is a useful technique to detect circulating tumor cells in patients with colorectal carcinomas. Applying negative and positive immunomagnetic beads successively yields the highest correlation with amount of tumor cells.
为建立一种检测循环肿瘤细胞(CTC)的新型分子诊断方法,将LS174T结肠癌细胞与正常血液进行系列稀释。另外从25例结直肠癌患者采集外周血样本。收集单核细胞(MNC),将其平均分成四份,然后通过四种方法富集癌细胞:方法A,非免疫磁珠法;方法B,阴性免疫磁珠法:使用CD45免疫磁珠去除白细胞;方法C,阳性免疫磁珠法:使用Ber-EP4免疫磁珠富集癌细胞;方法D,阴性-阳性免疫磁珠法:首先使用CD45免疫磁珠从MNC中去除白细胞,然后使用Ber-EP4免疫磁珠富集癌细胞。最后,采用实时定量RT-PCR监测β2-微球蛋白(β2M)和癌胚抗原(CEA)的mRNA表达。根据用cDNA十倍系列稀释(1 - 10⁴ IS174T细胞)制备的CEA mRNA外标和用cDNA十倍系列稀释(10² - 10⁷白细胞)制备的β2M mRNA外标,将相对CEA mRNA值参照β2M mRNA进行校正,得出CEA mRNA/β2M mRNA比值。在回收率实验中,单独使用CD45或Ber-EP4免疫磁珠时,发现癌细胞数量与CEA mRNA表达之间存在显著相关性。当先后使用CD45和Ber-EP4免疫磁珠时,发现存在高度显著相关性。方法D的灵敏度为每毫升血液中一个癌细胞。在25例结直肠癌患者中有19例检测到循环癌细胞。方法D获得的相对CEA mRNA值最小。Dukes' B、C和D期患者循环癌细胞的阳性检出率分别为25.0%(1/4)、83.3%(10/12)和88.9%(8/9)。免疫磁珠分离联合实时RT-PCR是检测结直肠癌患者循环肿瘤细胞的一种有用技术。先后应用阴性和阳性免疫磁珠与肿瘤细胞数量的相关性最高。